Cargando…

A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area

Obsessive-compulsive disorder (OCD) is a chronic illness in which patients do not achieve remission sufficiently with conventional medication. Deep repetitive transcranial magnetic stimulation (dTMS) for OCD neuromodulates the bilateral anterior cingulate cortex (ACC) and dorsal medial prefrontal co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikawa, Haruki, Osawa, Ryota, Sato, Akiko, Mizuno, Hoshimi, Noda, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605577/
https://www.ncbi.nlm.nih.gov/pubmed/36294453
http://dx.doi.org/10.3390/jcm11206133
_version_ 1784818101896871936
author Ikawa, Haruki
Osawa, Ryota
Sato, Akiko
Mizuno, Hoshimi
Noda, Yoshihiro
author_facet Ikawa, Haruki
Osawa, Ryota
Sato, Akiko
Mizuno, Hoshimi
Noda, Yoshihiro
author_sort Ikawa, Haruki
collection PubMed
description Obsessive-compulsive disorder (OCD) is a chronic illness in which patients do not achieve remission sufficiently with conventional medication. Deep repetitive transcranial magnetic stimulation (dTMS) for OCD neuromodulates the bilateral anterior cingulate cortex (ACC) and dorsal medial prefrontal cortex (mPFC), which are known to be impaired in OCD. While dTMS treatment for OCD has shown effective results overseas, TMS treatment for OCD has rarely been implemented in Japan, and its effectiveness is unknown. We conducted an FDA-approved dTMS protocol to 26 patients with OCD. In addition, individual exposure stimulation that elicited each patient’s obsessive thoughts was also combined during dTMS treatment. Before and after 30 sessions of TMS treatment, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was used to assess changes in the severity of each patient’s obsessive-compulsive disorder. Response to dTMS treatment in patients with OCD was determined by whether the total score on the Y-BOCS after a course of treatment was reduced by 30% or more compared with the score at baseline. The percentage of responders in this case series following the 30 sessions of dTMS treatment was 53.9%. In addition, total Y-BOCS scores and scores on each item were significantly improved. The percent changes in total Y-BOCS scores did not differ between the sexes or between on- and off-medication patients. No obvious adverse events were observed in this case series. In line with the results of TMS studies for OCD patients reported overseas, dTMS treatment for Japanese patients with OCD may have a favorable therapeutic effect.
format Online
Article
Text
id pubmed-9605577
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96055772022-10-27 A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area Ikawa, Haruki Osawa, Ryota Sato, Akiko Mizuno, Hoshimi Noda, Yoshihiro J Clin Med Article Obsessive-compulsive disorder (OCD) is a chronic illness in which patients do not achieve remission sufficiently with conventional medication. Deep repetitive transcranial magnetic stimulation (dTMS) for OCD neuromodulates the bilateral anterior cingulate cortex (ACC) and dorsal medial prefrontal cortex (mPFC), which are known to be impaired in OCD. While dTMS treatment for OCD has shown effective results overseas, TMS treatment for OCD has rarely been implemented in Japan, and its effectiveness is unknown. We conducted an FDA-approved dTMS protocol to 26 patients with OCD. In addition, individual exposure stimulation that elicited each patient’s obsessive thoughts was also combined during dTMS treatment. Before and after 30 sessions of TMS treatment, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was used to assess changes in the severity of each patient’s obsessive-compulsive disorder. Response to dTMS treatment in patients with OCD was determined by whether the total score on the Y-BOCS after a course of treatment was reduced by 30% or more compared with the score at baseline. The percentage of responders in this case series following the 30 sessions of dTMS treatment was 53.9%. In addition, total Y-BOCS scores and scores on each item were significantly improved. The percent changes in total Y-BOCS scores did not differ between the sexes or between on- and off-medication patients. No obvious adverse events were observed in this case series. In line with the results of TMS studies for OCD patients reported overseas, dTMS treatment for Japanese patients with OCD may have a favorable therapeutic effect. MDPI 2022-10-18 /pmc/articles/PMC9605577/ /pubmed/36294453 http://dx.doi.org/10.3390/jcm11206133 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ikawa, Haruki
Osawa, Ryota
Sato, Akiko
Mizuno, Hoshimi
Noda, Yoshihiro
A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title_full A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title_fullStr A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title_full_unstemmed A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title_short A Case Series of Deep Transcranial Magnetic Stimulation Treatment for Patients with Obsessive-Compulsive Disorder in the Tokyo Metropolitan Area
title_sort case series of deep transcranial magnetic stimulation treatment for patients with obsessive-compulsive disorder in the tokyo metropolitan area
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605577/
https://www.ncbi.nlm.nih.gov/pubmed/36294453
http://dx.doi.org/10.3390/jcm11206133
work_keys_str_mv AT ikawaharuki acaseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT osawaryota acaseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT satoakiko acaseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT mizunohoshimi acaseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT nodayoshihiro acaseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT ikawaharuki caseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT osawaryota caseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT satoakiko caseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT mizunohoshimi caseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea
AT nodayoshihiro caseseriesofdeeptranscranialmagneticstimulationtreatmentforpatientswithobsessivecompulsivedisorderinthetokyometropolitanarea